Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9151
Sight Sciences
SGHT
$448M
| $321K | ﹤0.01% |
36,732
+36,634
| +37,382% | +$407K |
|
9152
PUT
Perdoceo Education
PRDO
$2B
| $321K | ﹤0.01% |
23,900
+6,600
| +38% | +$92.4K |
|
|
AAN
9153
CALL
DELISTED
The Aaron's Company Inc
AAN
| $321K | ﹤0.01% |
33,200
+8,300
| +33% | +$107K |
|
9154
AllianzIM U.S. Equity Buffer20 Nov ETF
NVBW
$96.3M
| $321K | ﹤0.01% |
12,150
-418
| -3% | -$10.8K |
|
9155
PUT
Douglas Emmett
DEI
$1.96B
| $321K | ﹤0.01% |
26,000
+3,200
| +14% | +$46.4K |
|
|
BSCN
9156
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
| $320K | ﹤0.01% |
15,199
-15,549
| -51% | -$327K |
|
9157
AllianzIM U.S. Equity Buffer20 Mar ETF
MARW
$88.1M
| $320K | ﹤0.01% |
+12,566
| New | +$315K |
|
9158
CALL
Hancock Whitney
HWC
$6.4B
| $320K | ﹤0.01% |
8,800
+5,300
| +151% | +$247K |
|
9159
Lifestance Health
LFST
$4.75B
| $320K | ﹤0.01% |
43,111
+42,761
| +12,217% | +$237K |
|
9160
First Trust Japan AlphaDEX Fund
FJP
$264M
| $320K | ﹤0.01% |
7,065
-141,598
| -95% | -$6.22M |
|
9161
CALL
RLJ Lodging Trust
RLJ
$1.67B
| $320K | ﹤0.01% |
30,200
+27,600
| +1,062% | +$310K |
|
|
ME
9162
PUT
DELISTED
23andMe Holding Co
ME
| $320K | ﹤0.01% |
7,020
-2,920
| -29% | -$141K |
|
9163
PUT
Theravance Biopharma
TBPH
$881M
| $320K | ﹤0.01% |
29,500
-3,700
| -11% | -$39.1K |
|
9164
CALL
Cohen & Steers
CNS
$4.36B
| $320K | ﹤0.01% |
5,000
+3,100
| +163% | +$216K |
|
9165
Biomea Fusion
BMEA
$95.7M
| $320K | ﹤0.01% |
10,309
-13,521
| -57% | -$168K |
|
9166
CALL
Biohaven
BHVN
$2.21B
| $320K | ﹤0.01% |
23,400
-11,200
| -32% | -$178K |
|
9167
CALL
Gentex
GNTX
$5.03B
| $320K | ﹤0.01% |
11,400
+200
| +2% | +$5.63K |
|
9168
PUT
Procore
PCOR
$9.09B
| $319K | ﹤0.01% |
5,100
-9,500
| -65% | -$555K |
|
|
SVM
9169
PUT
Silvercorp Metals
SVM
$2.66B
| $319K | ﹤0.01% |
83,600
+2,600
| +3% | +$8.56K |
|
9170
CALL
Immersion
IMMR
$249M
| $319K | ﹤0.01% |
35,700
-1,800
| -5% | -$13.6K |
|
9171
PUT
Direxion Daily MSCI India Bull 2X ETF
INDL
$56.9M
| $318K | ﹤0.01% |
8,000
-4,500
| -36% | -$190K |
|
9172
Matthews China Active ETF
MCH
$22.6M
| $318K | ﹤0.01% |
+13,220
| New | +$337K |
|
9173
Novanta
NOVT
$6.3B
| $318K | ﹤0.01% |
2,001
-1,358
| -40% | -$209K |
|
9174
FT Vest US Equity Enhance & Moderate Buffer ETF June
XJUN
$139M
| $318K | ﹤0.01% |
9,903
+3,117
| +46% | +$98.2K |
|
9175
FT Vest US Equity Buffer ETF November
FNOV
$1.24B
| $318K | ﹤0.01% |
+8,465
| New | +$311K |
|
Similar funds
Citadel Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Citadel Advisors held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citadel Advisors withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Citadel Advisors opened a new position in Keurig Dr Pepper worth $238M.
- Citadel Advisors's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Citadel Advisors added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Citadel Advisors's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Citadel Advisors fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Citadel Advisors's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Citadel Advisors opened 1,466 new positions and closed 1,652 in Q1 2023.
- Citadel Advisors's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.